HCG vs LOTUSEYE: Stock Comparison
HEALTHCARE GLOB. ENT. is the larger company by market capitalisation. HEALTHCARE GLOB. ENT. shows a lower P/E, a higher ROE and a higher ROCE, while LOTUS EYE HOSP & INST L shows faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
HCG leads 6; LOTUSEYE leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | HCG | LOTUSEYE |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | HCG | LOTUSEYE |
|---|---|---|
| Live Price | ₹591.45 | ₹110 |
| Day Change | 1% | 0.42% |
| Volume | 51,707 | 14,710 |
| 52-Week High | ₹803.95 | ₹147 |
| 52-Week Low | ₹513.3 | ₹97.59 |
| Distance from 52W High | -26.43% | -25.17% |
Valuation
| Metric | HCG | LOTUSEYE |
|---|---|---|
| Market Cap | ₹8,817 Cr | ₹227 Cr |
| P/E Ratio | 385.98x | 2,955x |
| P/B Ratio | 6.62x | 4.09x |
| EPS | ₹0.92 | ₹0.04 |
| Book Value | ₹94.45 | ₹28.92 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | HCG | LOTUSEYE |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.5% | 18.2% |
| EPS Growth (TTM YoY) | -71.2% | 0% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | HCG | LOTUSEYE |
|---|---|---|
| ROE | 0.91% | 0.13% |
| ROCE | 5.66% | 1.15% |
| Net Margin | 0.54% | 0.15% |
| Operating Margin | 7.04% | 1.5% |
| Debt to Equity | 0.35x | 0.19x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | HCG | LOTUSEYE |
|---|---|---|
| Promoter Holding | 9.94% | 37.39% |
| FII Holding | 2.69%▼ 0.05 pp | 0% |
| DII Holding | 20.77%▲ 1.57 pp | 0.02% |
| Public Holding | 12.32%▼ 1.53 pp | 59.85% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HEALTHCARE GLOB. ENT. and LOTUS EYE HOSP & INST L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.